Evelin Balaguer

Mrs. Evelin Balaguer

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Journal of Tissue Viability
Verified
Journal Article
Closed access
MSM. Montserrat Sánchez-Lorente
M. Montserrat Sánchez-Lorente
ESEnrique Sanchis-Sánchez
Enrique Sanchis-Sánchez
PGPablo García-Molina
Pablo García-Molina
EBEvelin Balaguer
Evelin Balaguer
JBJosé María Blasco
José María Blasco

26 December 2023 in Medicina
Verified
Journal Article
Open access
PDF file
AGAna María Garcés-Carrasco
Ana María Garcés-Carrasco
ESEnric Santacatalina-Roig
Enric Santacatalina-Roig
CCCarlos Carretero-Márquez
Carlos Carretero-Márquez
Elena Chover-SierraElena Chover-Sierra
Elena Chover-Sierra
Antonio Martinez-SabaterAntonio Martinez-Sabater
Antonio Martinez-Sabater
EBEvelin Balaguer
Evelin Balaguer
Background and Objectives: The increase in indications for hematopoietic cell transplants (HCTs) has led to the development of new care options after said transplant, such as home care after transplantation, which improves the patients’ quality of life. The main purpose of this research is to analyze the differences in the appearance of post-transplant complications between patients having underwent autologous HCT with at-home post-transplant modalities and those under in-hospital post-transplant care. Materials and Methods: An observational, analytical, longitudinal, and retrospective study of cases and controls. All transplanted people in the domiciliary model since 2020 are included as cases (20 subjects). For each case, two controls (40 subjects) are proposed among patients who received an autologous transplant in a hospital in the last five years with a similar demographic and pathological base profile in each case. Results: No significant differences were found between cases and controls, except for the Karnofsky value, which was higher in people receiving home treatment (91.7% vs. 87.74%; p = 0.05). The average number of days of the process post-transplantation was more significant at home (processing days 22.4 ± 2.6; post-transplantation days of 16.4 ± 2.08 versus 21.21 ± 4.18, with a mean of 15.51 ± 3.96 days post-transplant (days of the process p = 0.022; days post-transplant p = 0.002)). There is a more significant presence of neutropenic fever, mucositis, and positive blood cultures in the post-transplant patients who remain in the hospital. In contrast, the patients receiving home care post-transplantation undergo significantly more weight loss. Regarding the odds ratio of the appearance of adverse events, in the hospital setting, it is up to 8.5 times more likely to encounter neutropenic fever, 4.63 times more likely for mucositis, and 6.65 times more likely for the presence of pathogens in blood cultures. Conclusions: The home care modality in the post-transplant phase does not show an inferiority in conditions in the management and safety of the patient concerning the appearance of adverse events. However, more significant weight loss is detected in patients at home, and an increased risk of episodes of neutropenic fever, mucositis, and positive blood cultures for patients in hospital settings.

AGAna María Garcés-Carrasco
Ana María Garcés-Carrasco
ESEnric Santacatalina-Roig
Enric Santacatalina-Roig
CCCarlos Carretero-Márquez
Carlos Carretero-Márquez
Antonio Martinez-SabaterAntonio Martinez-Sabater
Antonio Martinez-Sabater
EBEvelin Balaguer
Evelin Balaguer
Introduction: The SARS-CoV-2 pandemic generated the need to keep immunosuppressed patients away from hospital institutions for as long as possible. This in turn stimulated the implementation of a home hospitalization model for autologous hematopoietic stem-cell transplantation (HSCT). Purpose: To analyze whether there are significant differences in post-transplantation complications related to catheters observed in patients treated in the home-transplant care modality compared to patients treated in the hospital. Methodology: Observational, analytical, longitudinal, and retrospective study of cases and controls. A convenience sample was chosen, in which the cases comprised 20 patients included in the home HSCT care model. For each patient, it was considered suitable to propose two controls among those who received autologous transplantation in the last five years with a baseline demographic and pathological profile similar to the case for whom they were control. Results: The home patients achieved an average of 22.4 ± 2.6 days of evolution with an average of 16.4 ± 2.08 days post-transplant, compared to the hospital process with an average of 21.21 ± 4.18 days of evolution and 15.51 ± 3.96 days post-transplant (evolution days p = 0.022; post-transplant days p = 0.002). A higher percentage of use of parenteral nutrition (p = 0.036) and transfusions (p = 0.003) was observed during the post-transplant phase in the hospital. The rest of the therapeutic measures did not show significant differences. When analyzing the frequency of adverse effects in the post-transplant phase, a significant increase in neutropenic fever (OR = 8.55) and positive blood cultures (OR = 6.65) was observed in hospital patients. Any other significant differences in other variables related to PICC were found (presence and days of neutropenic fever, catheter infection, complications, pathogens, admission to the ICU, or death). Concerning local complications (pain, DVT, Medical adhesive-related Skin Injury, and erythema), there was more erythema in the hospital (p = 0.056). Conclusions: The results obtained indicate that regarding the appearance of complications associated with PICCs in home hospitalization HSCT patients, there are no significant differences compared to hospitalization, so that home care can be a safe context for people with these lines

1 July 2012
Verified
Journal Article
Closed access
PGPablo García-Molina
Pablo García-Molina
EBEvelin Balaguer
Evelin Balaguer
JBJoan Enric Torra I Bou
Joan Enric Torra I Bou
AAAdan Alvarez-Ordiales
Adan Alvarez-Ordiales
CQCristina Quesada-Ramos
Cristina Quesada-Ramos
José Verdú-SorianoJosé Verdú-Soriano
José Verdú-Soriano

25 September 2025 in Nursing Open
Verified
Journal Article
Open access
Pablo Buck Sainz-RozasPablo Buck Sainz-Rozas
Pablo Buck Sainz-Rozas
EBEvelin Balaguer
Evelin Balaguer
PGPablo García-Molina
Pablo García-Molina
PMPedro García Martínez
Pedro García Martínez
Aim: To analyse the general ability of second‐degree nursing students at the ‐REDACTED‐ to calculate, prepare, and administer paediatric medication.Design: A descriptive, analytical and cross‐sectional study was carried out through a gamified educational innovation project: “Medication Contest” following the STROBE statement.Methods: The study included all 224 students enrolled in the second year of nursing. The expert faculty created and validated an ad hoc questionnaire with 30 multiple‐choice questions. These responses were analysed to evaluate mathematical, conceptual, and concentration‐related competencies. Secondary variables were calculated, and correlations with the total score were examined. All variables were correlated with the final score, and their predictive capacities were analysed. To differentiate competencies, the 50 highest scores were compared to the rest of the participants.Results: Out of the 224 participants, 50 qualified for the second phase, with 37 achieving the best results. The median final score was 3/30 (IQR 6.3), differentiating 8.8 and 2.3 (p < 0.001) between those included and not in the top 50. Twenty‐three primary variables and all secondary variables significantly correlated with the total score. Mathematical competence was the main predictor variable of the final score (R2 = 0.609). All secondary variables were discriminatory.Public Contribution: The general ability to calculate, prepare, and administer paediatric medication in the 2nd year nursing population is deficient. Mathematical competence is the predictor variable of the final score, identifying an area of intervention and the evaluation on which to intervene.Tweetable Gamification enhances medication calculation training for nursing students through competitive quizzes and simulations.

30 June 2025 in International Journal of Wound Research
Verified
Journal Article
Open access
PDF file
Pablo Buck Sainz-RozasPablo Buck Sainz-Rozas
Pablo Buck Sainz-Rozas
AGAnna Gros-Turpin
Anna Gros-Turpin
EBEvelin Balaguer
Evelin Balaguer
IMIsabel María Mora Morillo
Isabel María Mora Morillo
JPJulia De Frutos Pecharroman
Julia De Frutos Pecharroman
PGPablo García-Molina
Pablo García-Molina
Introduction. The extreme fragility of neonatal skin, particularly in extremely preterm infants, underscores the need for effective preventive measures. This study aims to validate and design a decalogue for the prevention of dependency-related skin lesions (DRSL) in the neonatal population, based on existing consensus documents. Methods. The Delphi method was employed to validate the content of the decalogue through expert consultation across Spain. Key criteria—including relevance, clarity, ambiguity, simplicity, satisfaction, and applicability—were assessed using a 4-point Likert scale and a 10-point scale, with a 75% agreement threshold for validation. Descriptive statistics were used to analyze responses. Items not meeting the threshold were revised based on qualitative feedback and re-evaluated. The final list of interventions was established through consensus in the second round. Results. A total of 23 experts participated in the first round, and 20 in the second. Across both rounds, all items were validated with a high level of agreement. In the second round, all items exceeded 85% agreement for relevance, clarity, ambiguity, and simplicity. The average satisfaction (9.36–9.47) and applicability (9.09–9.42) revealed a high level of agreement concerning the clinical applicability of the Decalogue. The decalogue outlines essential measures for preventing DRSL in neonates, including risk assessment, postural changes, the use of specialized pressure-relieving surfaces, and monitoring of device-related pressure points. It also highlights the importance of tailored skin care based on neonatal maturity and the need for thorough documentation of preventive interventions. Discussion. Consensus achieved via the Delphi process substantiates the Decalogue’s capacity to effectively articulate key preventive strategies with clarity and brevity. Moreover, its implementation will foster evidence-based care practices, ultimately enhancing the quality of care in neonatal units. However, ongoing efforts are required to further improve DRSL prevention and continuously update strategies in light of emerging evidence.